August 13, 2020 – Congressman Rodney Davis helped introduce a bipartisan bill that protects patients from increased out-of-pocket prescription drug costs in the midst of the COVID-19 pandemic. H.R. 7647, also known as the Preserving Patient Savings on Drug Costs Act, will stop costly copay accumulator programs from insurers. It will delay the Department of Health and Human Services’ 2021 Notice of Benefit and Payment Parameter rule from becoming active for a year after the public health emergency due to COVID-19 has ended.
“Making prescription drugs more affordable for everyone is one of my top priorities and a bipartisan goal shared by our fellow lawmakers in Congress,” said Rep. Davis. “Patients should not face even more financial barriers to receiving the drugs they need to stay healthy, especially during this pandemic, and particularly for those with chronic conditions who are vulnerable to COVID-19. I’m proud to join Congressman McEachin and Congresswoman Watson Coleman in introducing this bipartisan legislation so we can provide financial relief and promote the health of patients while this pandemic continues.”
